Feb 27, 2017 at 10:15 | Source: Moneycontrol.com
With maintaining underperform rating on Bharti Airtel and unchanged target price at Rs 295, Credit Suisse 'tit-for-tat' aggression from Bharti is a departure from its historical passive response to competition.
Feb 20, 2017 at 10:36 | Source: CNBC-TV18
Even though the sector has been a rank underperformer in the past, Indian telecom stocks are very attractive from a three-year perspective, according to S Naren, Executive Director at Chief Investment Officer at ICICI Prudential.
Feb 06, 2017 at 11:25 | Source: CNBC-TV18
Surajit Pal, Research Analyst at Prabhudas Lilladher, said the pharma sector is undergoing a transition and all the large midcaps will underperform.
Jan 04, 2017 at 09:20 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying HCL Tech, Larsen & Toubro, Tata Chemicals and Zee Entertainment while he feels that banks will underperform and advises selling Bank of Baroda.
Jan 03, 2017 at 13:01 | Source: CNBC-TV18
The countrys pharma sector plagued by several issues including regulatory and pricing pressure underperformed Nifty losing nearly 14-15 percent in 2016. US-based drugmakers could see a pricing pressure of 10 percent in 2017 as well, according to Intas Pharmaceuticals.
Jan 02, 2017 at 15:21 | Source: CNBC-TV18
Banks are over-owned sector and is set to underperform this year, Shankar Sharma, Vice-chairman and Joint Managing Director of First Global Securities said, advising investors to steer clear of the sector. He added that many accounts will likely become non-performing assets in 2017 which will put pressure on banks.
Nov 08, 2016 at 10:37 | Source: CNBC-TV18
Speaking to CNBC-TV18 Pramod Gubbi of Ambit said that the pharma sector will be under pressure. He said pharma has been neglected or has underperformed.
Nov 08, 2016 at 10:18 | Source: CNBC-TV18
Hemant Thukral of Aditya Birla Money is of the view that Larsen and Toubro will continue to underperform and feels that ICICI Bank may test Rs 290.
Sep 12, 2016 at 11:18 | Source: CNBC-TV18
Given the underperformance in IT and Pharma space, the two can be the hiding places and may outperform in the broader market, says Yogesh Radke of Edelweiss Securities.
Sep 08, 2016 at 10:35 | Source: CNBC-TV18
The analysts are bearish on the entire IT pack and believe that the sector will underperform in coming quarters. However, industry body Nasscom says that various factors are the reason behind volatility in the sector.